Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 81 to 90 of 511

TitleReference numberPublishedLast updated
Tisagenlecleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 25 years and underTA975
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancerHTG719
Artificial intelligence (AI)-derived software to help clinical decision making in strokeHTG708
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma in people 3 years and overTA967
Satralizumab for preventing relapses in neuromyelitis optica spectrum disorders (terminated appraisal)TA960
Ritlecitinib for treating severe alopecia areata in people 12 years and overTA958
Daratumumab in combination for treating newly diagnosed systemic amyloid light-chain amyloidosisTA959
Digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people: early value assessmentHTG713
Etrasimod for treating moderately to severely active ulcerative colitis in people aged 16 and overTA956
Vitamin B12 deficiency in over 16s: diagnosis and managementNG239

Results per page

  1. 10
  2. 25
  3. 50
  4. All